Journal of Allergy and Clinical Immunology: Global

As the AAAAI's Open Access journal, JACI: Global publishes reports describing original research - basic, translational and clinical - related to all aspects of allergy, immunology, and related fields. This very broad scope mirrors the scope of its two companion journals. In addition to translational content, JACI: Global publishes basic science, Phase I/II clinical trials, population studies, as well as regionally relevant research relating to allergy and immunology. JACI: Global provides a (high-)quality outlet for authors whose funders require them to publish in a Gold Open Access journal. One of the journal's hallmarks is its geographic diversity, with an emphasis on global and regional research and practice. This makes the journal particularly appealing to authors working in Research4Life countries, with waivers or deep discounts of accepted Article Processing Charges (APCs) automatically provided by our publisher, Elsevier. JACI: Global also provides an important service to the growing number of funders who have joined Plan S (the European cOAlition S initiative) that requires full Open Access of research funded by its members, including the Gates Foundation, the Wellcome Trust, UK Research and Innovation, and the World Health Organization (see https://www.coalition-s.org).